Eastern Equine Encephalitis virus (EEEV) is a mosquito‑borne alphavirus in the Togaviridae family that causes severe encephalitis in horses and humans. It circulates primarily between ornithophilic Culiseta melanura mosquitoes and passerine birds in freshwater swamp habitats of eastern North America and the Caribbean.
Epidemiology and Virology
Eastern Equine Encephalitis virus is an enveloped virus with a single‑stranded positive‑sense RNA genome and an icosahedral nucleocapsid. It belongs to the genus Alphavirus and is one of the most virulent members of this group. Genetic analyses have identified several lineages, with lineage I causing most human and equine disease. The virus maintains an enzootic cycle involving Culiseta melanura mosquitoes and passerine birds in freshwater swamps. Because Culiseta melanura rarely feeds on mammals, transmission to horses and humans requires “bridging” mosquitoes such as Aedes, Coquillettidia and Culex species that feed on both birds and mammals. Horses and humans are dead‑end hosts and cannot amplify the virus. EEEV is endemic in Atlantic and Gulf Coast states of the United States and in parts of Canada, Central and South America and the Caribbean. Human cases are sporadic, with risk highest from late summer to early autumn when vector populations peak. There is no licensed human vaccine or specific antiviral therapy; equine vaccines are available.
Clinical Manifestations and Outbreaks
After an incubation period of about 4–10 days, EEEV infection may remain asymptomatic or produce a systemic illness with fever, chills, myalgia and malaise. In a minority of infected individuals, the virus invades the central nervous system, causing meningitis or encephalitis characterized by high fever, severe headache, vomiting, altered mental status and seizures. Neuroinvasive disease carries a case fatality rate of around one‑third, and survivors often have permanent neurologic deficits. Equine infections typically manifest as anorexia, depression and ataxia progressing to encephalomyelitis and recumbency, with high mortality. Large outbreaks were documented in the United States in the 1930s and again in the 2019 season. Prevention relies on vaccination of horses and reduction of mosquito exposure through habitat modification, larvicide application and personal protective measures such as repellents and protective clothing. Laboratory diagnosis is achieved by virus isolation, nucleic acid detection or serologic assays. Eastern Equine Encephalitis virus remains a rare but serious arboviral threat in eastern North America and the Caribbean. Understanding its enzootic cycle and the role of bridging vectors is essential for effective surveillance and control. Prompt recognition and supportive medical care can reduce mortality, but long‑term neurologic sequelae are common in survivors. Related Terms: Western equine encephalitis virus, Venezuelan equine encephalitis virus, St. Louis encephalitis virus, West Nile virus, Alphavirus